J. Brachmann, T. Beyer, W. Schöls, C. Schmitt, M. Montero, W. Knollmann, T. Hilbel, W. Kübler; Pros and cons of drugs that prolong ventricular refractoriness, E
No takes yet. Share an insight, caveat, or question.
Brachmann et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: